<DOC>
	<DOCNO>NCT00000867</DOCNO>
	<brief_summary>The purpose study determine safety effectiveness memantine , experimental drug , improve AIDS dementia complex ( ADC ) . The symptom ADC improve zidovudine ( ZDV ) . However , ZDV therapy associate significant toxicity , effectiveness ZDV seem decrease second third year therapy . The effectiveness antiretroviral drug treatment ADC know , important explore alternative therapy .</brief_summary>
	<brief_title>A Study Evaluate Use Memantine In Combination With Anti-HIV Drugs Treat AIDS Dementia Complex ( ADC )</brief_title>
	<detailed_description>The sign symptom AIDS Dementia Complex alleviate zidovudine ( ZDV ) . However , ZDV therapy associate significant toxicity , particularly bone marrow suppression . The efficacy ZDV appear decrease second third year therapy . It know whether reflect cumulative toxicity . In addition , efficacy antiretroviral agent remain uncertain . Hence , adjunctive therapy cognitive motor symptom AIDS important . Patients randomize one follow 2 arm : Arm 1 receives memantine plus concurrent antiretroviral therapy ; Arm 2 receives placebo plus concurrent antiretroviral therapy . The initial dose memantine increase week next 3 week , unless maximum tolerate dose reach . Following 16-week evaluation period 4-week washout prior re-assessment . After washout period , patient , include formerly randomize placebo arm , give opportunity receive open-label , 12-week administration memantine . [ AS PER AMENDMENT 4/6/99 : The open-label phase extend 48 week total 60 week therapy . Patients receive initial 12 week open-label treatment eligible still 48-week open-label treatment phase . ]</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>AIDS Dementia Complex</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>Inclusion Criteria You may eligible study : Are HIV positive . Have diagnose AIDS dementia complex ( ADC ) . Have estimate IQ least 70 ( onset ADC ) ability read 6th grade level . Have impair mental skill . Are age18 old . Exclusion Criteria You eligible study : Have history neurologic disease unrelated HIV infection . Have history chronic seizure head injury . Have history central nervous system infection . Have certain cancer . Have psychiatric illness . Have active AIDSdefining opportunistic infection . Are pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Administration , Oral</keyword>
	<keyword>AIDS Dementia Complex</keyword>
	<keyword>Zidovudine</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Memantine</keyword>
</DOC>